BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37874293)

  • 1. Using singular value decomposition to analyze drug/β-cyclodextrin mixtures: insights from X-ray powder diffraction patterns.
    Hasegawa K; Goto S; Tsunoda C; Kuroda C; Okumura Y; Hiroshige R; Wada-Hirai A; Shimizu S; Yokoyama H; Tsuchida T
    Phys Chem Chem Phys; 2023 Nov; 25(42):29266-29282. PubMed ID: 37874293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of the Metastable α-Form of Indomethacin Induced by the Addition of 2-Hydroxypropyl-β-Cyclodextrin, Causing Supersaturation (Spring) and Its Sustaining Deployment (Parachute).
    Wada-Hirai A; Shimizu S; Ichii R; Tsunoda C; Hiroshige R; Fujita M; Li YP; Shimada Y; Otsuka Y; Goto S
    J Pharm Sci; 2021 Nov; 110(11):3623-3630. PubMed ID: 34364701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Heat Treatment on Indomethacin-Cimetidine Mixture; Investigation of Drug-Drug Interaction Using Singular Value Decomposition in FTIR Spectroscopy.
    Otsuka Y; Kuwashima W; Tanaka Y; Yamaki Y; Shimada Y; Goto S
    J Pharm Sci; 2021 Mar; 110(3):1142-1147. PubMed ID: 33035536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process.
    Bandi N; Wei W; Roberts CB; Kotra LP; Kompella UB
    Eur J Pharm Sci; 2004 Oct; 23(2):159-68. PubMed ID: 15451004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular recognizable ion-paired complex formation between diclofenac/indomethacin and famotidine/cimetidine regulates their aqueous solubility.
    Kasai T; Shiono K; Otsuka Y; Shimada Y; Terada H; Komatsu K; Goto S
    Int J Pharm; 2020 Nov; 590():119841. PubMed ID: 32976923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-state NMR investigation of indomethacin-cyclodextrin complexes in PEG 6000 carrier.
    Wulff M; Aldén M; Tegenfeldt J
    Bioconjug Chem; 2002; 13(2):240-8. PubMed ID: 11906261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of gabapentin polymorphs in gabapentin/excipient mixtures using solid state
    Tinmanee R; Larsen SC; Morris KR; Kirsch LE
    J Pharm Biomed Anal; 2017 Nov; 146():29-36. PubMed ID: 28843174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cogrinding with β-cyclodextrin on the solid state fentanyl.
    Ogawa N; Higashi K; Nagase H; Endo T; Moribe K; Loftsson T; Yamamoto K; Ueda H
    J Pharm Sci; 2010 Dec; 99(12):5019-29. PubMed ID: 20821388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of X-ray powder diffraction and differential scanning calorimetry for identification of counterfeit drugs.
    Jendrzejewska I; Zajdel P; Pietrasik E; Barsova Z; Goryczka T
    Monatsh Chem; 2018; 149(5):977-985. PubMed ID: 29720770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation.
    Ficarra R; Ficarra P; Di Bella MR; Raneri D; Tommasini S; Calabrò ML; Gamberini MC; Rustichelli C
    J Pharm Biomed Anal; 2000 Aug; 23(1):33-40. PubMed ID: 10898152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
    Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
    Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
    Jambhekar S; Casella R; Maher T
    Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. insights into novel supramolecular complexes of two solid forms of norfloxacin and β-cyclodextrin.
    Chattah AK; Mroue KH; Pfund LY; Ramamoorthy A; Longhi MR; Garnero C
    J Pharm Sci; 2013 Oct; 102(10):3717-24. PubMed ID: 23904189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.
    Zhou Q; Wei X; Dou W; Chou G; Wang Z
    Carbohydr Polym; 2013 Jun; 95(2):733-9. PubMed ID: 23648035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fexofenadine/cyclodextrin inclusion complexation: phase solubility, thermodynamic, physicochemical, and computational analysis.
    Omari MM; Badwan AA; Zughul MB; Eric J; Davies D
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1205-15. PubMed ID: 18058317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of beta-lapachone and methylated beta-cyclodextrin solid-state systems.
    Cunha-Filho MS; Dacunha-Marinho B; Torres-Labandeira JJ; Martínez-Pacheco R; Landín M
    AAPS PharmSciTech; 2007 Jul; 8(3):E60. PubMed ID: 17915810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation,
    Giri BR; Lee J; Lim DY; Kim DW
    Drug Dev Ind Pharm; 2021 Feb; 47(2):319-328. PubMed ID: 33576707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.